XERS
Xeris Biopharma Holdings, Inc.
$8.70
+0.42 (+5.07%)
At close · Jul 15
Market Cap
$1.50B
Shares
172,642,055
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Marla S. Persky | Lead Independent Director | Appointed | 2026-06-30 |
| John Shannon | Chairperson of the Board | Appointed | 2026-06-30 |
| Nerissa Kreher | Class III director | Appointed | 2026-06-30 |